STOCK TITAN

DarkIris closes public offering for $6M gross

DarkIris received $4.59 million net for working capital and other general corporate purposes.

(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
6-K

Rhea-AI Filing Summary

DarkIris Inc. (DKI) closed a best-efforts public offering on October 9, 2026, for $6 million in aggregate gross proceeds, before placement agent fees and expenses and excluding warrant exercises. It included 898,965 Units, each with one Class A ordinary share and one Warrant, and 3,267,701 Pre-Funded Units, each with one Pre-Funded Warrant and one Warrant. The company issued 898,965 Class A ordinary shares, 3,267,701 Pre-Funded Warrants, and 4,166,666 Warrants.

DarkIris received $4.59 million in net proceeds after placement agent fees and offering expenses, for working capital and other general corporate purposes. Units were priced at $1.44 each and Pre-Funded Units at $1.4399 each. Warrants are immediately exercisable at $2.04 per share and expire six months after issuance; their zero exercise price option is capped at 52,380,944 shares. A 9.99% beneficial-ownership limit applies to Warrant and Pre-Funded Warrant exercises; the Pre-Funded Warrant terms provide limited exceptions.

Insights

Analyzing...

Aggregate gross proceeds $6 million Before placement agent fees and other estimated expenses; excludes warrant exercises
Net proceeds $4.59 million After placement agent fees and offering expenses
Class A ordinary shares issued 898,965 shares October 2026 offering
Pre-Funded Warrants issued 3,267,701 warrants Each exercisable for one Class A ordinary share
Warrants issued 4,166,666 warrants Each exercisable for one Class A ordinary share
Warrant exercise price $2.04 per share Each Warrant
Zero exercise price option cap 52,380,944 shares Maximum aggregate shares issuable under the option
Beneficial-ownership limit 9.99% Applies to Warrant and Pre-Funded Warrant exercises, subject to limited exceptions for Pre-Funded Warrants
best efforts public offering financial
"priced a best efforts public offering"
A best efforts public offering is a way a company sells new shares or bonds where the broker or bank agrees to try to sell as many securities as possible but does not promise to buy any unsold portion. Think of it like a salesperson taking items on consignment: they will work to sell them, but the seller bears the risk if some remain unsold. For investors, this matters because it can signal weaker demand and greater uncertainty about how many securities will actually be placed and how the price may move.
Pre-Funded Warrant financial
"each consisting of one pre-funded warrant"
A pre-funded warrant is a financial instrument that gives the holder the right to buy shares of a company's stock at a set price, with most of the purchase cost already paid upfront. It functions like a nearly fully paid option, allowing investors to secure shares quickly while minimizing the amount of additional money they need to invest later. This helps investors gain ownership rights efficiently, often used to avoid certain regulatory restrictions or to prepare for future stock purchases.
cashless basis financial
"Warrants may be exercised on a cashless basis"
An agreement executed on a cashless basis lets a holder convert or exercise a security (like options, warrants, or conversion rights) without paying money upfront; instead the holder receives a smaller number of shares equal in value to what the cash would have purchased. Think of trading a coupon for fewer slices of a cake rather than handing over cash for the full slice. For investors, it affects how much ownership and dilution occur and avoids immediate cash outlays.
zero exercise price option financial
"pursuant to a “zero exercise price option”"
A zero exercise price option is a stock option that lets the holder convert the option into shares without paying any cash upfront because the strike price is set at zero. For investors, these awards act like immediate share grants: they increase the company’s outstanding shares (dilution), are treated as employee compensation for accounting and tax purposes, and signal how management is being paid, which can affect future earnings and shareholder value.
beneficially own regulatory
"would beneficially own in excess of 9.99%"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much did DKI raise in its October 2026 offering?

DarkIris reported $6 million in aggregate gross proceeds and $4.59 million in net proceeds. Gross proceeds were before placement agent fees and other estimated expenses and excluded warrant exercises; net proceeds were after placement agent fees and offering expenses.

What are DKI’s Pre-Funded Warrant terms?

Each Pre-Funded Warrant is immediately exercisable for one Class A ordinary share at $0.0001 per share and may be exercised until exercised in full. Subject to limited exceptions, a holder and its affiliates may not exercise above a 9.99% beneficial-ownership limit.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of October 2026

 

Commission File Number: 001-42795

 

DarkIris Inc.

(Registrant’s Name)

 

6/F, Cheong Sun Tower

No. 118 Wing Lok Street

Sheung Wan, Hong Kong

(Address of Principal Executive Offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒                 Form 40-F ☐

 

 

 

 

 

 

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

 

Pricing and Closing of $6 Million Best Efforts Offering

 

On October 8, 2026, DarkIris Inc. (the “Company”) priced a best efforts public offering for the sale of Units and Pre-Funded Units, each as defined below, for aggregate gross proceeds to the Company of $6 million, before deducting placement agent fees and other estimated expenses payable by the Company, excluding the exercise of any Warrants offered. The offering was comprised of (i) 898,965 units (each a “Unit”), each consisting of one Class A ordinary share, par value $0.0016 per share, of the Company (the “Class A Ordinary Shares”), and one warrant to purchase one Class A Ordinary Share (each a “Warrant”), and (ii) 3,267,701 pre-funded units (each a “Pre-Funded Unit”), each consisting of one pre-funded warrant (each a “Pre-Funded Warrant”) to purchase one Class A Ordinary Share, and one Warrant, offered in lieu of Units to certain purchasers who so elected. In the aggregate, the Company issued 898,965 Class A Ordinary Shares, 3,267,701 Pre-Funded Warrants to purchase up to 3,267,701 Class A Ordinary Shares, and 4,166,666 Warrants. The public offering price of the Units was $1.44 per Unit. The public offering price of the Pre-Funded Units was $1.4399 per Pre-Funded Unit, representing the public offering price per Unit, minus $0.0001, and the exercise price per Pre-Funded Warrant is equal to $0.0001 per share.

 

Each of the Warrants is exercisable to purchase one Class A Ordinary Share at an exercise price of $2.04 per share, subject to adjustment as set forth therein. The Warrants are exercisable immediately upon issuance and will expire six (6) months following the date of issuance. If, at the time of exercise, there is no effective registration statement or prospectus available for the issuance or resale of the Class A Ordinary Shares underlying the Warrants, the Warrants may be exercised on a cashless basis in accordance with their terms. The Warrants may also be exercised pursuant to a “zero exercise price option,” whether or not there is an effective registration statement or prospectus available for the issuance or resale of the Class A Ordinary Shares underlying the Warrants. In such event, the number of Class A Ordinary Shares issuable upon exercise of the Warrants shall be determined in accordance with the formula set forth therein; provided, however, that in no event shall the aggregate number of Class A Ordinary Shares issuable upon exercise of the Warrants pursuant to such option exceed 52,380,944 shares.

 

A holder of the Warrants may not exercise any portion of such Warrants to the extent that, after giving effect to such exercise, such holder (together with its affiliates) would beneficially own in excess of 9.99% of the number of Class A Ordinary Shares outstanding immediately after giving effect to such exercise.

 

Each Pre-Funded Warrant is immediately exercisable for one Class A Ordinary Share at an exercise price of $0.0001 per share and may be exercised at any time until exercised in full. Subject to limited exceptions, a holder may not exercise any portion of its Pre-Funded Warrants to the extent that the holder, together with its affiliates, would beneficially own in excess of 9.99% of the Class A Ordinary Shares outstanding immediately after giving effect to such exercise.

 

The securities were offered pursuant to a securities purchase agreement, dated October 8, 2026, between the Company and the purchasers named therein (the “Securities Purchase Agreement”), and the Company’s registration statement on Form F-1 (File No. 333-299200), as amended, declared effective by the Securities and Exchange Commission (the “SEC”) on October 8, 2026, and a related registration statement on Form F-1 filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended (File No. 333-299359), which became effective upon filing on October 8, 2026.

 

On October 8, 2026, the Company entered into a placement agency agreement (the “Placement Agency Agreement”) with Prime Number Capital, LLC (the “Placement Agent”), pursuant to which the Placement Agent acted as sole placement agent for the offering and would receive at the closing of the offering a cash fee equal to 5.0% of the aggregate gross proceeds raised in this offering, and reimbursement for legal fees and other out-of-pocket fees, costs and expenses in the amount of up to $80,000.

 

The offering closed on October 9, 2026. The Company received net proceeds of $4.59 million, after deducting placement agent fees and offering expenses. The Company intends to use the net proceeds from the offering for working capital and other general corporate purposes.

 

The foregoing descriptions of the Securities Purchase Agreement, the Placement Agency Agreement, the Warrants and Pre-Funded Warrants do not purport to be complete and are qualified in their entirety by copies of such documents filed as Exhibits 10.1, 10.2, 4.1 and 4.2, respectively, to this Current Report on Form 6-K and are incorporated herein by reference.

 

A copy of the Company’s press release announcing the offering is furnished as Exhibit 99.1 to this report.

 

This report does not constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

 

EXHIBIT INDEX

 

The following exhibits are being filed herewith:

 

Exhibit No.   Description
4.1   Form of Warrant
4.2   Form of Pre-Funded Warrant
10.1   Form of Securities Purchase Agreement
10.2   Placement Agency Agreement
99.1   Press Release dated October 8, 2026

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  DarkIris Inc.
   
  By: /s/ Hong Zhifang
  Name: Hong Zhifang
  Title: Chief Executive Officer

 

Date: October 9, 2026

 

3

 

Exhibit 99.1

 

DarkIris Inc. Announces Pricing of $6 Million Public Offering

 

HONG KONG, October 8, 2026 /GLOBE NEWSWIRE/ — DarkIris Inc. (Nasdaq: DKI) (the “Company” or “DarkIris”), an innovative technology provider in the digital media and entertainment sector, today announced that it has priced a best-efforts public offering with gross proceeds to the Company expected to be approximately $6 million, before deducting placement agent fees and other estimated expenses payable by the Company, excluding the exercise of any warrant offered.

 

The offering is comprised of 4,166,666 units (each, a “Unit”), each consisting of (i) one Class A ordinary share of the Company, par value $0.0016 per share (the “Class A Ordinary Shares”), and (ii) one warrant to purchase one Class A Ordinary Share or otherwise receive a greater number of Class A Ordinary Shares pursuant to the zero exercise price option described below (each, a “Warrant”). The public offering price per Unit is $1.44, or in lieu of Units, 4,166,666 pre-funded units (each a “Pre-Funded Unit”), each consisting of (i) one pre-funded warrant to purchase one Class A Ordinary Share (each, a “Pre-Funded Warrant”), and (ii) one Warrant. The public offering price per Pre-funded Unit is $1.4399, which is equal to the public offering price per Unit to be sold in the offering, minus the $0.0001 exercise price per Pre-Funded Warrant. Each of the Warrants will have an exercise price of $2.04 per Class A Ordinary Share and will be immediately exercisable upon issuance and expire six (6) months after the issuance date. The Pre-Funded Warrants will be immediately exercisable and may be exercised at any time until exercised in full. For each Pre-Funded Unit sold in the offering, the number of Units in the offering will be decreased on a one-for-one basis. The Warrants may also be exercised on a zero cash exercise option, pursuant to which the holder may exchange each warrant for approximately 12 Class A ordinary shares that are issuable on a cash exercise of the Warrants.

 

The offering is expected to close on or about October 9, 2026, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the offering for working capital and other general corporate purposes.

 

Prime Number Capital, LLC is acting as the sole placement agent for the offering.

 

The Units and Pre-funded Units and underlying securities are being offered by the Company pursuant to a registration statement on Form F-1 (File No. 333-299200) initially filed by the Company with the Securities and Exchange Commission (the “SEC”) on September 30, 2026, and declared effective by SEC on October 8, 2026, and Form F-1MEF (File No. 333-299359). The offering is being made only by means of a written preliminary prospectus and final prospectus that will form a part of the registration statement. A final prospectus relating to the offering will be filed with the SEC and will be available on the SEC’s website at www.sec.gov. Electronic copies of the final prospectus relating to this offering may be obtained, when available, by contacting Prime Number Capital, LLC at 12 E 49 St, Floor 27, New York, NY 10017 or by email at info@pncps.com.

 

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

 

 

 

 

About DarkIris Inc.

 

DarkIris Inc. (Nasdaq: DKI) is an innovative, growth-oriented public company focused on AI-driven digital media and content production technologies. Through advanced production capabilities, including its artificial intelligence platform, aideptus.com, the Company aims to provide creators, studios, and developers with generative AI solutions designed to streamline creative workflows and enhance digital content production experiences. For more information, please visit the Company’s website at www.darkiris.com.

 

Forward-Looking Statements

 

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performances, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks, including, but not limited to, the following: the Company’s ability to achieve its goals and strategies, the Company’s future business development and plans for future business development, including its financial conditions and results of operations, product and service demand and acceptance, reputation and brand, the impact of competition and pricing, changes in technology, government regulations, fluctuations in general economic and business conditions, the Company’s ability to comply with Nasdaq continued listing standards and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the U.S. Securities and Exchange Commission (“SEC”). For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, as well as its current reports on Form 6-K and other filings, all of which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

 

For investor and media inquiries, please contact:

 

DarkIris Inc.

 

Investor Relations Department

Email: dki@darkiris.com

 

Ascent Investor Relations LLC

 

Tina Xiao

Phone: +1 646-932-7242

Email: investors@ascent-ir.com

 

 

 

Filing Exhibits & Attachments

53 documents

Keep reading